RIPK1 Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in Mice

D. Karunakaran; M.-A. Nguyen; M. Geoffrion; D. Vreeken; Z. Lister; H.S. Cheng; N. Otte; P. Essebier; H. Wyatt; J.W. Kandiah; R. Jung; F.J. Alenghat; A. Mompeon; R. Lee; C. Pan; E. Gordon; A. Rasheed; A.J. Lusis; P. Liu; L.P. Matic; U. Hedin; J.E. Fish; L. Guo; F. Kolodgie; R. Virmani; J.M. van Gils; K.J. Rayner

doi:10.1161/CIRCULATIONAHA.118.038379

RIPK1 Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in Mice

D. Karunakaran, M.-A. Nguyen, M. Geoffrion, D. Vreeken, Z. Lister, H.S. Cheng, N. Otte, P. Essebier, H. Wyatt, J.W. Kandiah, R. Jung, F.J. Alenghat, A. Mompeon, R. Lee, C. Pan, E. Gordon, A. Rasheed, A.J. Lusis, P. Liu, L.P. MaticU. Hedin, J.E. Fish, L. Guo, F. Kolodgie, R. Virmani, J.M. van Gils, K.J. Rayner

Research output: Contribution to journal › Article › peer-review

125 Scopus citations

Original language	Undefined
Journal	Circulation
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.118.038379
State	Published - 2021

Access to Document

10.1161/CIRCULATIONAHA.118.038379

Cite this

Karunakaran, D., Nguyen, M.-A., Geoffrion, M., Vreeken, D., Lister, Z., Cheng, H. S., Otte, N., Essebier, P., Wyatt, H., Kandiah, J. W., Jung, R., Alenghat, F. J., Mompeon, A., Lee, R., Pan, C., Gordon, E., Rasheed, A., Lusis, A. J., Liu, P., ... Rayner, K. J. (2021). RIPK1 Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in Mice. Circulation. https://doi.org/10.1161/CIRCULATIONAHA.118.038379

Karunakaran, D, Nguyen, M-A, Geoffrion, M, Vreeken, D, Lister, Z, Cheng, HS, Otte, N, Essebier, P, Wyatt, H, Kandiah, JW, Jung, R, Alenghat, FJ, Mompeon, A, Lee, R, Pan, C, Gordon, E, Rasheed, A, Lusis, AJ, Liu, P, Matic, LP, Hedin, U, Fish, JE, Guo, L, Kolodgie, F, Virmani, R, van Gils, JM & Rayner, KJ 2021, 'RIPK1 Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in Mice', Circulation. https://doi.org/10.1161/CIRCULATIONAHA.118.038379

@article{6922dcda6cfe472b8b685985cdeaea27,

title = "RIPK1 Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in Mice",

author = "D. Karunakaran and M.-A. Nguyen and M. Geoffrion and D. Vreeken and Z. Lister and H.S. Cheng and N. Otte and P. Essebier and H. Wyatt and J.W. Kandiah and R. Jung and F.J. Alenghat and A. Mompeon and R. Lee and C. Pan and E. Gordon and A. Rasheed and A.J. Lusis and P. Liu and L.P. Matic and U. Hedin and J.E. Fish and L. Guo and F. Kolodgie and R. Virmani and {van Gils}, J.M. and K.J. Rayner",

year = "2021",

doi = "10.1161/CIRCULATIONAHA.118.038379",

language = "Undefined",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - RIPK1 Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in Mice

AU - Karunakaran, D.

AU - Nguyen, M.-A.

AU - Geoffrion, M.

AU - Vreeken, D.

AU - Lister, Z.

AU - Cheng, H.S.

AU - Otte, N.

AU - Essebier, P.

AU - Wyatt, H.

AU - Kandiah, J.W.

AU - Jung, R.

AU - Alenghat, F.J.

AU - Mompeon, A.

AU - Lee, R.

AU - Pan, C.

AU - Gordon, E.

AU - Rasheed, A.

AU - Lusis, A.J.

AU - Liu, P.

AU - Matic, L.P.

AU - Hedin, U.

AU - Fish, J.E.

AU - Guo, L.

AU - Kolodgie, F.

AU - Virmani, R.

AU - van Gils, J.M.

AU - Rayner, K.J.

PY - 2021

Y1 - 2021

UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-85100069767&partnerID=MN8TOARS

U2 - 10.1161/CIRCULATIONAHA.118.038379

DO - 10.1161/CIRCULATIONAHA.118.038379

M3 - Article

C2 - 33222501

SN - 0009-7322

JO - Circulation

JF - Circulation

ER -

RIPK1 Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in Mice

Access to Document

Other files and links

Cite this